All Posts

UF Research Spotlight

University of Florida investigators Brian S. Wilson, MD, PhD, and Mark Atkinson, PhD, have teamed up with colleagues at the City of Hope National Medical Center in Duarte, Calif., to devise a new combination therapy that reverses established type 1 diabetes in mice.

23% of U.S. Teen Population Has Diabetes

About 23% of adolescents in the United States had type 2 diabetes or were on the verge of developing the condition in 2008, up from 9% less than a decade before, according to a new study released in Pediatrics.

iPhone blood glucose meter now available

The iBGStar blood glucose meter has arrived. This new “micro” meter can be used on its own, or can be connected to an iPhone or iPod touch to manage and communicate blood glucose information.

Friends for Life Conference

Join an international group of diabetes clinicians, researchers, physicians, adults, children, and families with diabetes at the Children with Diabetes Friends for Life Conference, July 3 – 8, 2012 in Orlando, FL.

UF Diabetes Administrator to speak at Centers of Excellence Conference

UF Diabetes Center of Excellence Administrator Les Jebson has been asked to serve as a guest presenter at the upcoming Diabetes Centers of Excellence Conference being held May 17-18th in Atlanta, GA. His presentation will emphasize the use of population metrics data to drive the organization strategy and mission of a diabetes center.

College Scholarships Available

The Diabetes Scholars Foundation Scholarship Program is available to incoming freshmen seeking a higher education at an accredited four-year university, college, technical, or trade school. The deadline to apply is May 15, 2012. Click here to learn more.

Anastasia Albanese-O’Neill named a Jonas Scholar

Anastasia Albanese-O’Neill, a diabetes nurse educator in the UF Health pediatric diabetes clinics was recently named a Jonas Scholar. This distinguished award will help her complete her doctoral studies and develop leadership skills. Care, Lead, Inspire continues at the College of Nursing.

First Artificial Pancreas Outpatient Trial in the U.S. Gets FDA Approval

Did you hear the great news about the first artificial pancreas outpatient trial in the U.S. being approved by the FDA? To help ensure that progress like the artificial pancreas continues to improve the lives of those with diabetes by simply sending an email to your members of Congress.

Tell Congress to increase diabetes funding!

Some Members of Congress want to derail ongoing diabetes research and undermine proven prevention efforts despite the fact that a staggering 100+ million Americans either have or are at risk of developing diabetes.